Last viewed:
EYES
Prices are updated after-hours
EYES
|
$4.14
-0.24%
3.14%
|
Health Technology
(0.0% 1d)
(0.0% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(Infinity%
volume)
Earnings Calendar:
Market Cap:
http://www.secondsight.com
Sec
Filling
|
Patents
| 112 employees
Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.
china
prosthetics
add to watch list
Paper trade
email alert is off
Press-releases
Nerve Repair and Regeneration Global Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2028 | DelveInsight
Published: 2023-08-17
(Crawled : 21:00)
- prnewswire.com
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
| 20.9%
| O: -0.11%
H: 0.61%
C: 0.1%
NVRO
|
$12.07
-2.03%
0.0%
390K
|
Health Technology
| -36.26%
| O: -0.99%
H: 2.2%
C: -1.52%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
| -3.86%
| O: -1.02%
H: 0.0%
C: 0.0%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
| 32.35%
| O: -0.06%
H: 0.12%
C: -1.41%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| 1.11%
| O: -0.88%
H: 0.0%
C: 0.0%
NURO
|
News
|
$4.28
17.26%
14.72%
250K
|
Health Technology
| -42.39%
| O: -1.64%
H: 5.26%
C: 0.14%
LIVN
|
$52.31
-0.85%
-0.86%
430K
|
Health Technology
| -4.67%
| O: -0.46%
H: 0.0%
C: 0.0%
BWAY
|
$4.835
0.94%
0.93%
41K
|
Health Technology
| 52.06%
| O: 4.13%
H: 11.89%
C: -2.74%
expected
global
growth
market
Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System
Published: 2023-07-11
(Crawled : 12:00)
- biospace.com/
VANI
|
$1.7
-5.82%
-6.18%
190K
|
Manufacturing
| 41.54%
| O: 0.0%
H: 0.77%
C: -3.85%
orion
update
system
study
Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
Published: 2023-06-14
(Crawled : 11:00)
- biospace.com/
VANI
|
$1.7
-5.82%
-6.18%
190K
|
Manufacturing
| 17.2%
| O: -0.64%
H: 1.92%
C: -2.56%
conference
group
medical
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study
Published: 2023-04-04
(Crawled : 11:00)
- biospace.com/
VANI
|
$1.7
-5.82%
-6.18%
190K
|
Manufacturing
| 100.09%
| O: 0.04%
H: 1.09%
C: -0.22%
ongoing
grant
medical
funding
study
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division
Published: 2023-03-21
(Crawled : 11:00)
- feed.businesswire.com
VANI
|
$1.7
-5.82%
-6.18%
190K
|
Manufacturing
| 92.41%
| O: 8.75%
H: 0.0%
C: -10.58%
business
offering
medical
Vivani Medical to Present at the ThinkEquity Investor Conference
Published: 2022-10-17
(Crawled : 11:00)
- biospace.com/
EYES
|
$4.14
-0.24%
3.14%
|
Health Technology
| Email alert
Add to watchlist
conference
Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)
Published: 2022-08-31
(Crawled : 11:00)
- biospace.com/
EYES
|
$4.14
-0.24%
3.14%
|
Health Technology
| -2.82%
| O: -2.58%
H: 1.2%
C: -0.24%
Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.
Published: 2022-08-30
(Crawled : 12:00)
- biospace.com/
EYES
|
$4.14
-0.24%
3.14%
|
Health Technology
| -5.48%
| O: -2.74%
H: 0.0%
C: 0.0%
Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting
Published: 2022-07-29
(Crawled : 11:00)
- biospace.com/
EYES
|
$4.14
-0.24%
3.14%
|
Health Technology
| 123.78%
| O: -2.7%
H: 3.33%
C: 0.0%
meeting
approval
Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®
Published: 2022-04-14
(Crawled : 12:20)
- biospace.com/
EYES
|
$4.14
-0.24%
3.14%
|
Health Technology
| 211.28%
| O: 0.0%
H: 18.8%
C: 5.26%
report
air
ceo
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001753926-23-000869
4
2023-06-29
2023-06-28
Buy
P
3000
4000
0001753926-23-000869
4
2023-06-29
2023-06-27
Buy
P
1000
1000
0001753926-23-000817
4
2023-06-20
2023-06-15
Buy
A
32121
32121
0001753926-23-000815
4
2023-06-20
2023-06-15
Buy
A
32121
32121
0001753926-23-000813
4
2023-06-20
2023-06-15
Buy
A
32121
32121
0001753926-23-000811
4
2023-06-20
2023-06-15
Buy
A
32121
32121